Free product worth Rs 499 on all myUpchar products
Biproate 333 Mg/145 Mg Tablet CR is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Epilepsy. The alternative uses of Biproate 333 Mg/145 Mg Tablet CR have also been explained below.
The right dosage of Biproate 333 Mg/145 Mg Tablet CR depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Common side effects of Biproate 333 Mg/145 Mg Tablet CR include Loss of appetite. Besides the aforementioned side effects, there are other adverse effects of Biproate 333 Mg/145 Mg Tablet CR as well, which are listed below. Usually, these side effects of Biproate 333 Mg/145 Mg Tablet CR go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Biproate 333 Mg/145 Mg Tablet CR's effect during pregnancy is Severe and Mild while nursing. In addition, Biproate 333 Mg/145 Mg Tablet CR's effects on the liver, heart and kidney are discussed below in the Biproate 333 Mg/145 Mg Tablet CR related warnings section.
Biproate 333 Mg/145 Mg Tablet CR is contraindicated in people with pre-existing medical conditions like Depression as it can result in adverse effects. The section on Biproate 333 Mg/145 Mg Tablet CR contraindications lists all such conditions.
Besides this, Biproate 333 Mg/145 Mg Tablet CR may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Biproate 333 Mg/145 Mg Tablet CR, it is important to know that it is not safe while driving, and is not habit-forming.
Biproate 333 Mg/145 Mg Tablet CR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Biproate 333 Mg/145 Mg Tablet CR safe for pregnant women?
Biproate Cr has many dangerous side effects in pregnant women. If you are pregnant, do not consume Biproate Cr without medical advice.
Is the use of Biproate 333 Mg/145 Mg Tablet CR safe during breastfeeding?
Side effects of Biproate Cr on breastfeeding women are very mild.
What is the effect of Biproate 333 Mg/145 Mg Tablet CR on the Kidneys?
Biproate Cr rarely harms the kidneys.
What is the effect of Biproate 333 Mg/145 Mg Tablet CR on the Liver?
Very few cases of side effects of Biproate Cr on the liver have been reported.
What is the effect of Biproate 333 Mg/145 Mg Tablet CR on the Heart?
Using Biproate Cr does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Biproate 333 Mg/145 Mg Tablet CR unless your doctor advises you to do so -
Is this Biproate 333 Mg/145 Mg Tablet CR habit forming or addictive?
No, you will not get addicted to Biproate 333 Mg/145 Mg Tablet CR.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Biproate 333 Mg/145 Mg Tablet CR. So it is best to avoid driving.
Is it safe?
Biproate 333 Mg/145 Mg Tablet CR is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, taking Biproate 333 Mg/145 Mg Tablet CR can treat mental disorders.
Interaction between Food and Biproate 333 Mg/145 Mg Tablet CR
Taking Biproate 333 Mg/145 Mg Tablet CR with food does not harm your health.
Interaction between Alcohol and Biproate 333 Mg/145 Mg Tablet CR
Consumption of alcohol and Biproate 333 Mg/145 Mg Tablet CR together may have severe effects on your health.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1243-1245
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 417-418
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stavzor (valproic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Depakene (valproic acid)
